GPC Biotech Inc. Report issue

For profit Phase 3
Founded: Martinsried Germany (1997)
Status: Acquired by Agennix (2009)

Organization Overview

First Clinical Trial
2006
NCT00313456
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

satraplatin (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1